Prognostic significance of t(14;18) and bcl-2 gene

Martinka, Magda; Comeau, Terry
December 1997
Clinical & Investigative Medicine;Dec97, Vol. 20 Issue 6, p364
Academic Journal
Evaluates whether there is an association between the presence of t(14;18) and bcl-2 gene expression in patients with follicular small cleaved cell lymphoma (FSCCL) and diffuse large cell lymphoma (DLCL). Materials and methods used; Clinical stage at diagnosis and t(14;18); Response to treatment and t(14;18); Analytical discussion of the results; Conclusions.


Related Articles

  • Intravascular Lymphomatosis Presenting as Rapidly Progressive Dementia. Heinrich, Alexander; Vogelgesang, Silke; Kirsch, Michael; Khaw, Alexander V. // European Neurology;2005, Vol. 54 Issue 1, p55 

    Discusses a case of intravascular lymphomatosis presenting as rapidly progressive dementia. Case history; Treatment options.

  • Overexpression of c-myb in Leukaemic and Non-Leukaemic Variants of Cutaneous T-Cell Lymphoma. Poenitz, N.; Simon-Ackermann, J.; Gratchev, A.; Qadoumi, M.; Klemke, C.-D.; Stadler, R.; Kremer, A.; Radenhausen, M.; Henke, U.; Assaf, C.; Utikal, J.; Goerdt, S.; Dippel, E. // Dermatology (10188665);2005, Vol. 211 Issue 2, p84 

    Background: The c-myb oncogene is a transcription factor that regulates proliferation, differentiation and apoptosis of haematopoietic cells and activated T cells by binding to promoter sequences of such genes as c-myc or bcl-2 that are expressed in cutaneous T-cell lymphoma (CTCL). Objective:...

  • Atypical Poorly Differentiated Cutaneous T-Cell Lymphoma with an Angiocentric Growth Pattern Presenting Histologically as Vasculitis. Laetsch, B.; Hofbauer, G.; Kempf, W.; Burg, G.; Dummer, R. // Dermatology (10188665);2005, Vol. 210 Issue 4, p341 

    We report the case of a 41-year-old patient with an aggressive cutaneous T-cell lymphoma (CTCL) initially presenting on histology as lymphocytic vasculitis. On repeated histological examination and by molecular biology work-up, the diagnosis of an unclassifiable CTCL could eventually be...

  • Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index. Nicolaides; Fountzilas; Zoumbos; Skarlos; Kosmidis; Pectasides; Karabelis; Giannakakis; Symeonidis; Papadopoulos; Antoniou; Pavlidis // Oncology;1998, Vol. 55 Issue 5, p405 

    Several clinical prognostic factors have been identified that predict treatment outcome in patients with diffuse large cell lymphomas. An International Non-Hodgkin’s Lymphoma Prognostic Index (IPI) has been recently formulated. We tried to identify the clinical prognostic factors that...

  • Vaccination Strategies in the Treatment of Lymphomas. Veelken, Hendrik; Osterroth, Frank // Oncology;2002, Vol. 62 Issue 3, p187 

    Malignant lymphomas are clonal neoplasms of lymphoid origin. By definition, all cells of the malignant clone have undergone the same rearrangement of antigen receptor genes and express identical antigen receptor molecules (immunoglobulin for B cell lymphomas, T cell receptor for T cell...

  • non-Hodgkin's lymphoma:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p162 

    A definition of the term non-Hodgkin's lymphoma is presented. It refers to a lymphoma other than Hodgkin's disease. Non-Hodgkin's lymphomas may be classified into nodular or diffuse tumor patterns and by cell type. They can be also be classified into high, intermediate, and low grade malignancy...

  • Nutrients Contributing to One-Carbon Metabolism and Risk of Non-Hodgkin Lymphoma Subtypes. Stella Koutros; Yawei Zhang; Yong Zhu; Susan T. Mayne; Sheila Hoar Zahm; Theodore R. Holford; Brian P. Leaderer; Peter Boyle; Tongzhang Zheng // American Journal of Epidemiology;Feb2008, Vol. 167 Issue 3, p287 

    Because little is known about the etiology of non-Hodgkin lymphoma (NHL), a heterogeneous disease, and because dietary factors are modifiable, the authors examined the associations between nutrients related to one-carbon metabolism and risk of NHL in a population-based case-control study of...

  • Intravascular Large B Cell Lymphoma: An Elusive Cause of Pyrexia of Unknown Origin Diagnosed Postmortem. Holmes, N. E.; Gordon, C. L.; Lightfoot, N.; Crowley, P.; Buchanan, R. R.; Smith, C. L.; Johnson, P. D. R. // Clinical Infectious Diseases;11/1/2010, Vol. 51 Issue 9, pe61 

    Intravascular large B cell lymphoma (IVLBCL) is a rare cause of pyrexia of unknown origin. Because of its protean clinical manifestations, diagnosis is elusive and is often made postmortem. We report here a case of IVLBCL that evaded diagnosis despite multiple investigations in vivo for pyrexia...

  • Prevalence and Pattern of Autoimmune Conditions in Patients with Marginal Zone Lymphoma: A Single Institution Experience. DASANU, CONSTANTIN A.; BOCKORNY, BRUNO; GRABSKA, JOANNA; CODREANU, ION // Connecticut Medicine;Apr2015, Vol. 79 Issue 4, p197 

    Background: Increased risk of B-cell non-Hodgkin lymphoma (NHL) in patients with autoimmune diseases is a known fact. An association may exist between marginal zone lymphoma (MZL) and certain autoimmune conditions and vice-versa. Methods: Herein, we present the analysis of a series of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics